Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:2016:3896147.
doi: 10.1155/2016/3896147. Epub 2016 Oct 25.

High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications

Affiliations
Review

High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications

Han Wu et al. Mediators Inflamm. 2016.

Abstract

High mobility group box-1 (HMGB-1), a damage-associated molecular pattern, can be actively or passively released from various cells under different conditions and plays a pivotal role in the pathogenesis of inflammation and angiogenesis-dependent diseases. More and more evidence suggests that inflammation, in addition to its role in progression of diabetes, also promotes initiation and development of diabetic complications. In this review, we focus on the role of HMGB-1 in diabetes-related complications and the therapeutic strategies targeting HMGB-1 in diabetic complications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schema depicting the structure of HMGB-1 and the molecular mechanisms responsible for the role of HMGB-1 in inflammation. (a) HMGB-1 translocates from the nucleus to the cytoplasm under oxidative stress condition and then is actively (immune or active inflammatory cells) or passively (death, apoptosis, or necrosis cells) released outside the cells. Once it is released into the extracellular space, HMGB-1 in turn promotes oxidative stress by binding to its receptors (such as RAGE, TLR2, and TLR4). (b) Extracellular HMGB-1 binds to its receptors and induces inflammatory response via various signaling pathways involving NF-κB, MyD88, p38MAPK, ERK, and JNK.
Figure 2
Figure 2
Schematic representation of HMGB-1-mediated cellular signaling pathways in islet cells.

References

    1. Goodwin G. H., Sanders C., Johns E. W. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. European Journal of Biochemistry. 1973;38(1):14–19. doi: 10.1111/j.1432-1033.1973.tb03026.x. - DOI - PubMed
    1. Goodwin G. H., Johns E. W. The isolation and purification of the high mobility group (HMG) nonhistone chromosomal proteins. Methods in Cell Biology. 1977;16:257–267. doi: 10.1016/s0091-679x(08)60104-1. - DOI - PubMed
    1. Musumeci D., Roviello G. N., Montesarchio D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacology and Therapeutics. 2014;141(3):347–357. doi: 10.1016/j.pharmthera.2013.11.001. - DOI - PubMed
    1. Kang R., Chen R., Zhang Q., et al. HMGB1 in health and disease. Molecular Aspects of Medicine. 2014;40:1–116. doi: 10.1016/j.mam.2014.05.001. - DOI - PMC - PubMed
    1. Cai J., Wen J., Bauer E., Zhong H., Yuan H., Chen A. F. The role of HMGB1 in cardiovascular biology: danger signals. Antioxidants and Redox Signaling. 2015;23(17):1351–1369. doi: 10.1089/ars.2015.6408. - DOI - PubMed